These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17644843)

  • 1. On call. In your January 2007 article on cholesterol, you said that no-flush niacin does not lower cholesterol levels. But my problem is low HDL cholesterol. Will no-flush niacin help my HDL even if it won't lower my LDL cholesterol?
    Simon HB
    Harv Mens Health Watch; 2007 Jun; 11(11):7-8. PubMed ID: 17644843
    [No Abstract]   [Full Text] [Related]  

  • 2. Ask the doctor. I tried taking niacin to increase my HDL but didn't like the flushing it caused. A friend told me about no-flush niacin, which works like a charm. Why not tell your readers about it?
    Lee T
    Harv Heart Lett; 2010 Mar; 20(7):8. PubMed ID: 20586132
    [No Abstract]   [Full Text] [Related]  

  • 3. When taking niacin to help lower my LDL and raise my HDL, I have experienced a hot and itchy "flushing" sensation, which I understand is very common. Are there any "no flush" niacin products on the market?
    Heart Advis; 2007 Nov; 10(11):8. PubMed ID: 18271102
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't overlook niacin for treating cholesterol problems. If you can conquer or cope with the "niacin flush," this B vitamin can do wonders for cholesterol.
    Harv Heart Lett; 2004 Apr; 14(8):4-5. PubMed ID: 15100082
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid in the treatment of hyperlipidaemia.
    Drexel H
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():5-6. PubMed ID: 18001312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of dyslipoproteinemia risk factor. Lipid therapy must become multidimensional].
    MMW Fortschr Med; 2008 Jun; 150(26-27):52-3. PubMed ID: 18681233
    [No Abstract]   [Full Text] [Related]  

  • 10. Antioxidant versus lipid-altering therapy--some answers, more questions.
    Freedman JE
    N Engl J Med; 2001 Nov; 345(22):1636-7. PubMed ID: 11757512
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding niacin formulations.
    Pieper JA
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S308-14. PubMed ID: 12240702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.
    Davidson MH; Ballantyne CM
    Am J Cardiol; 2008 Apr; 101(8A):1B-2B. PubMed ID: 18375235
    [No Abstract]   [Full Text] [Related]  

  • 14. On call. I am 57 years old, and as far as I know, my health is excellent. At my last check-up, my doctor said that I was in perfect health except that my cholesterol was too high. Please tell me what you think of these results: cholesterol 243, LDL cholesterol 162, HDL cholesterol 68, and triglycerides 86. Everything else was "normal".
    Simon HB
    Harv Mens Health Watch; 2007 Apr; 11(9):7-8. PubMed ID: 17443914
    [No Abstract]   [Full Text] [Related]  

  • 15. "Flush-free niacin": dietary supplement may be "benefit-free".
    Norris RB
    Prev Cardiol; 2006; 9(1):64-5. PubMed ID: 16407706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.
    Jaffer FA
    J Am Coll Cardiol; 2009 Nov; 54(19):1795-6. PubMed ID: 19874993
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
    Bays HE; Ballantyne C
    Curr Opin Lipidol; 2009 Dec; 20(6):467-76. PubMed ID: 19779335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ask the doctor. My doctor is focused on keeping my LDL in a good range, but she doesn't seem too concerned that my HDL is on the low side. Shouldn't it get the same attention?
    Lee TH
    Harv Heart Lett; 2005 Apr; 15(8):8. PubMed ID: 15818856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.